189 related articles for article (PubMed ID: 19936146)
1. Patient adherence and preference considerations in managing cardiovascular risk: focus on single pill and amlodipine/atorvastatin fixed combination.
Aslam F; Haque A; Lee V; Foody J
Patient Prefer Adherence; 2009 Nov; 3():61-6. PubMed ID: 19936146
[TBL] [Abstract][Full Text] [Related]
2. Does a single-pill antihypertensive/lipid-lowering regimen improve adherence in US managed care enrolees? A non-randomized, observational, retrospective study.
Hussein MA; Chapman RH; Benner JS; Tang SS; Solomon HA; Joyce A; Foody JM
Am J Cardiovasc Drugs; 2010; 10(3):193-202. PubMed ID: 20387911
[TBL] [Abstract][Full Text] [Related]
3. Amlodipine/atorvastatin fixed-dose combination: a review of its use in the prevention of cardiovascular disease and in the treatment of hypertension and dyslipidemia.
McKeage K; Siddiqui MA
Am J Cardiovasc Drugs; 2008; 8(1):51-67. PubMed ID: 18303938
[TBL] [Abstract][Full Text] [Related]
4. Amlodipine/Atorvastatin: a review of its use in the treatment of hypertension and dyslipidaemia and the prevention of cardiovascular disease.
Curran MP
Drugs; 2010; 70(2):191-213. PubMed ID: 20108992
[TBL] [Abstract][Full Text] [Related]
5. Can combining different risk interventions into a single formulation contribute to improved cardiovascular disease risk reduction? The single pill of amlodipine/atorvastatin.
Hobbs FD
Vasc Health Risk Manag; 2007; 3(5):711-9. PubMed ID: 18078022
[TBL] [Abstract][Full Text] [Related]
6. A single-pill combination of amlodipine besylate and atorvastatin calcium.
Blank R
Drugs Today (Barc); 2006 Mar; 42(3):157-75. PubMed ID: 16628258
[TBL] [Abstract][Full Text] [Related]
7. Can combining different risk interventions into a single formulation contribute to improved cardiovascular disease risk reduction? Rationale and design for an international, open-label program to assess the effectiveness of a single pill (amlodipine/atorvastatin) to attain recommended target levels for blood pressure and lipids (The JEWEL Program).
Hobbs FD; Gensini G; Mancini GB; Manolis AJ; Bauer B; Böhler S; Genest J; Feldman R; Harvey P; Jenssen TG; Metcalfe M; da Silva PM;
Int J Cardiol; 2006 Jun; 110(2):242-50. PubMed ID: 16338012
[TBL] [Abstract][Full Text] [Related]
8. Adherence with single-pill amlodipine/atorvastatin vs a two-pill regimen.
Patel BV; Leslie RS; Thiebaud P; Nichol MB; Tang SS; Solomon H; Honda D; Foody JM
Vasc Health Risk Manag; 2008; 4(3):673-81. PubMed ID: 18827917
[TBL] [Abstract][Full Text] [Related]
9. Amlodipine/atorvastatin single pill for the management of hypertensive patients with additional cardiovascular risk factors.
Blank R
Future Cardiol; 2006 Mar; 2(2):145-59. PubMed ID: 19804070
[TBL] [Abstract][Full Text] [Related]
10. A single-pill combination of amlodipine besylate and atorvastatin calcium (update).
Blank R; Hobbs FD; Zamorano J; Girerd X
Drugs Today (Barc); 2007 Mar; 43(3):157-77. PubMed ID: 17380213
[TBL] [Abstract][Full Text] [Related]
11. Treatment with Free Triple Combination Therapy of Atorvastatin, Perindopril, Amlodipine in Hypertensive Patients: A Real-World Population Study in Italy.
Perrone V; Veronesi C; Gambera M; Nati G; Perone F; Tagliabue PF; Degli Esposti L; Volpe M
High Blood Press Cardiovasc Prev; 2019 Oct; 26(5):399-404. PubMed ID: 31463886
[TBL] [Abstract][Full Text] [Related]
12. [One year persistence of atorvastatin and amlodipine fixed dose combination versus atorvastatin therapy].
Simonyi G; Ferenci T
Orv Hetil; 2016 Mar; 157(11):425-9. PubMed ID: 26947091
[TBL] [Abstract][Full Text] [Related]
13. Fixed combination of amlodipine and atorvastatin in cardiovascular risk management: patient perspectives.
Devabhaktuni M; Bangalore S
Vasc Health Risk Manag; 2009; 5(1):377-87. PubMed ID: 19475775
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness analysis of low density lipoprotein cholesterol-lowering therapy in hypertensive patients with type 2 diabetes in Korea: single-pill regimen (amlodipine/atorvastatin) versus double-pill regimen (amlodipine+atorvastatin).
Park JH; Lee YH; Ko SK; Cha BS
Epidemiol Health; 2015 Feb; 37():e2015010. PubMed ID: 25773438
[TBL] [Abstract][Full Text] [Related]
15. Results of a Markov model analysis to assess the cost-effectiveness of a single tablet of fixed-dose amlodipine and atorvastatin for the primary prevention of cardiovascular disease in Korea.
Liew D; Park HJ; Ko SK
Clin Ther; 2009 Oct; 31(10):2189-203; discussion 2150-1. PubMed ID: 19922890
[TBL] [Abstract][Full Text] [Related]
16. Treatment of Hypertensive and Hypercholesterolaemic Patients with the Triple Fixed Combination of Atorvastatin, Perindopril and Amlodipine: The Results of the CORAL Study.
Simon A; Dézsi CA
Adv Ther; 2019 Aug; 36(8):2010-2020. PubMed ID: 31183780
[TBL] [Abstract][Full Text] [Related]
17. A medication adherence and persistence comparison of hypertensive patients treated with single-, double- and triple-pill combination therapy.
Xie L; Frech-Tamas F; Marrett E; Baser O
Curr Med Res Opin; 2014 Dec; 30(12):2415-22. PubMed ID: 25222764
[TBL] [Abstract][Full Text] [Related]
18. Effects of Switching from Treatment with Amlodipine and Atorvastatin Using Two Pills to an Equal Dose of Single-Pill Therapy in Japanese Outpatients.
Kawada Y; Kubo T; Baba Y; Hirota T; Tanioka K; Yamasaki N; Kitaoka H
Acta Med Okayama; 2020 Apr; 74(2):103-108. PubMed ID: 32341583
[TBL] [Abstract][Full Text] [Related]
19. Is Time an Important Problem in Management of Hypertension and Hypercholesterolemia by Using an Amlodipine-Atorvastatin Single Pill Combination?
Zeng R; Wang M; Zhang L
Med Sci Monit; 2016 Jul; 22():2648-55. PubMed ID: 27459306
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of fix dose combination (atorvastatin and amlodipine) in treatment of uncontrolled hypertension and dyslipidemia.
Bashir S; Sherwani MU; Shabbir I; Batool A
J Ayub Med Coll Abbottabad; 2011; 23(3):97-100. PubMed ID: 23272446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
